Low Level of Cross-Reactive Antibodies to Pandemic Influenza (H1N1) 2009 Virus in Humans in Pre-Pandemic Period in Maharashtra, India

被引:0
|
作者
Sadhana S. Kode
Shailesh D. Pawar
Babasaheb V. Tandale
Saurabh S. Parkhi
Tanaji D. Barde
Akhilesh C. Mishra
机构
[1] National Institute of Virology (NIV)-Microbial Containment Complex (MCC),
[2] National Institute of Virology,undefined
来源
关键词
Pandemic influenza (H1N1) 2009; Hemagglutination inhibition assay; Microneutralization assay; Cross-reactive antibodies;
D O I
暂无
中图分类号
学科分类号
摘要
In India, the first outbreak of pandemic influenza (H1N1) 2009 (H1N1pdm) was reported from Panchgani, Maharashtra, in June 2009. Studies from several countries have revealed different levels of pre-existing immunity to H1N1pdm 2009 in various age groups. This study was undertaken using age-stratified pre-pandemic human sera to understand baseline cross-reactivity of antibodies against H1N1pdm. Using cut off antibody titers 20 and 40, overall cross-reactivity was 2.1 and 0.9% respectively by microneutralization assay; 1.2% and 0.7% by haemagglutination inhibition assay, respectively. Results showed higher baseline antibodies and cross-reactive antibodies in the 0–19 age group whereas the elderly age group (≥60) showed no cross-reactivity to H1N1pdm. The higher baseline and cross-reactive antibodies in 0–19 years age group could be because of higher positivity to seasonal H1N1 in that age group. Overall, low level of cross-reactive antibodies to H1N1pdm virus were found in humans in pre-pandemic period in Maharashtra, India.
引用
收藏
页码:36 / 38
页数:2
相关论文
共 50 条
  • [31] FROM SWINE TO HUMANS: THE A (H1N1) 2009 INFLUENZA PANDEMIC
    Girard, Marc P.
    BULLETIN DE L ACADEMIE VETERINAIRE DE FRANCE, 2010, 163 (02): : 109 - 117
  • [32] Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection
    Ahmed, Muhammad S.
    Jacques, Laura C.
    Mahallawi, Waleed
    Ferrara, Francesca
    Temperton, Nigel
    Upile, Nay
    Vaughan, Casey
    Sharma, Ravi
    Beer, Helen
    Hoschler, Katja
    McNamara, Paul S.
    Zhang, Qibo
    ANTIVIRAL RESEARCH, 2015, 114 : 106 - 112
  • [33] Cross-reactive T cells to pandemic influenza H1N1 are predominantly of an effector phenotype
    Sridhar, S.
    Begom, S.
    Bermingham, A.
    Bremang, S.
    Magtoto, M.
    Grass, L.
    Potiphar, L.
    Openshaw, P.
    Lalvani, A.
    IMMUNOLOGY, 2010, 131 : 176 - 176
  • [34] 2009 Influenza A (H1N1) Pandemic
    Kumate Rodriguez, Jesus
    CIRUGIA Y CIRUJANOS, 2009, 77 (03): : 157 - 158
  • [35] Pandemic: 2009 Influenza A (H1N1)
    Shulman, Stanford T.
    PEDIATRIC ANNALS, 2009, 38 (12): : 635 - 636
  • [36] 2009 pandemic influenza A(H1N1)
    Cazzadori, Angelo
    Conti, Michela
    Concia, Ercote
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2009, 4 (06): : 401 - 402
  • [37] 2009 H1N1 Influenza Pandemic
    Woo, Teri Moser
    JOURNAL OF PEDIATRIC HEALTH CARE, 2010, 24 (04) : 258 - 266
  • [38] Pandemic (H1N1) 2009 influenza
    Patel, M.
    Dennis, A.
    Flutter, C.
    Khan, Z.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 104 (02) : 128 - 142
  • [39] Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians
    Booy, Robert
    Khandaker, Gulam
    Heron, Leon G.
    Yin, Jiehui
    Doyle, Bridget
    Tudo, Katherine K.
    Hueston, Linda
    Gilbert, Gwendolyn L.
    MacIntyre, C. Raina
    Dwyer, Dominic E.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (01) : 19 - 23
  • [40] Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08)
    Iorio, A. M.
    Camilloni, B.
    Lepri, E.
    Neri, M.
    Basileo, M.
    Azzi, A.
    4TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS, 2011, 4 : 50 - 58